tailieunhanh - Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: A new prognostic model for diffuse large B-cell lymphoma in the rituximab era

This study aimed to propose a new user-friendly, cost effective and robust risk model to facilitate risk stratification for diffuse large B-cell lymphoma (DLBCL) treated with frontline R-CHOP regimens. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN